New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
10:51 EDTSYY, NLY, CBI, NUAN, CNP, COH, SBGI, MDT, YPF, PRKROptions with increasing implied volatility
Options with increasing implied volatility: NUAN PRKR SBGI CBI YPF COH NLY MDT CNP SYY
News For NUAN;PRKR;SBGI;CBI;YPF;COH;NLY;MDT;CNP;SYY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
11:46 EDTCOHMovado surges after Q4 profit beats estimates
Subscribe for More Information
08:36 EDTMDTMedtronic receives FDA approval for CoreValve System
Subscribe for More Information
March 30, 2015
16:55 EDTMDTFDA expands use of CoreValve System
Subscribe for More Information
09:04 EDTMDTMedtronic announces Japanese approval of CoreValue System
Subscribe for More Information
March 26, 2015
10:29 EDTSBGISinclair Broadcast launches Sinclair Digital Ventures
Subscribe for More Information
08:05 EDTCBICB&I, Chiyoda an dZachry Group awarded contract for LNG liquefaction
Subscribe for More Information
March 25, 2015
16:05 EDTMDTMedtronic highlights data on patients undergoing laparoscopic colon resections
Subscribe for More Information
March 24, 2015
10:17 EDTNLYOptions with decreasing implied volatility
Options with decreasing implied volatility: FOLD NKTR GES VHC CTRP WSM WLL LNCO NLY ORCL
March 23, 2015
11:22 EDTNLYOptions with decreasing implied volatility
Options with decreasing implied volatility: FOLD NKTR RUSL XONE GES CTRP WSM NLY ADBE ORCL
March 18, 2015
05:39 EDTMDTSt. Jude Medical downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded St. Jude Medical (STJ) to Market Perform saying competitive pressures will drive 2015 market share losses in the company's cardiac rhythm management business, which represents 50% of total sales. Wells believes the launch of CardioMEMS will not be strong enough to offset the headwinds in CRM unit. The firm thinks Boston Scientific's (BSX) earlier than expected approval for its next generation subcutaneous implantable cardioverter-defibrillator called Emblem will drive share gains against St. Jude and Medtronic (MDT) in the single chamber ICD market. Wells cut its price target range for St. Jude shares to $69-$70 from $73-$74. The medical technology company closed yesterday down $2.01 to $65.45.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use